Revance Therapeutics Statistics
Total Valuation
MBGYY has a market cap or net worth of 54.53 billion. The enterprise value is 152.76 billion.
| Market Cap | 54.53B |
| Enterprise Value | 152.76B |
Important Dates
The last earnings date was Wednesday, July 30, 2025.
| Earnings Date | Jul 30, 2025 |
| Ex-Dividend Date | May 9, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -6.98% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 622.83M |
Valuation Ratios
The trailing PE ratio is 6.82 and the forward PE ratio is 7.59.
| PE Ratio | 6.82 |
| Forward PE | 7.59 |
| PS Ratio | 0.33 |
| PB Ratio | 0.51 |
| P/TBV Ratio | 0.65 |
| P/FCF Ratio | 2.76 |
| P/OCF Ratio | 2.23 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.24, with an EV/FCF ratio of 7.73.
| EV / Earnings | 19.10 |
| EV / Sales | 0.95 |
| EV / EBITDA | 9.24 |
| EV / EBIT | 14.22 |
| EV / FCF | 7.73 |
Financial Position
The company has a current ratio of 1.32, with a Debt / Equity ratio of 1.16.
| Current Ratio | 1.32 |
| Quick Ratio | 0.87 |
| Debt / Equity | 1.16 |
| Debt / EBITDA | 7.81 |
| Debt / FCF | 6.30 |
| Interest Coverage | 64.35 |
Financial Efficiency
Return on equity (ROE) is 7.67% and return on invested capital (ROIC) is 2.68%.
| Return on Equity (ROE) | 7.67% |
| Return on Assets (ROA) | 2.06% |
| Return on Invested Capital (ROIC) | 2.68% |
| Return on Capital Employed (ROCE) | 4.70% |
| Revenue Per Employee | 967,259 |
| Profits Per Employee | 47,268 |
| Employee Count | 175,264 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 3.35 |
Taxes
In the past 12 months, MBGYY has paid 3.25 billion in taxes.
| Income Tax | 3.25B |
| Effective Tax Rate | 28.29% |
Stock Price Statistics
The stock price has decreased by -13.86% in the last 52 weeks. The beta is 0.92, so MBGYY's price volatility has been similar to the market average.
| Beta (5Y) | 0.92 |
| 52-Week Price Change | -13.86% |
| 50-Day Moving Average | 14.78 |
| 200-Day Moving Average | 14.78 |
| Relative Strength Index (RSI) | 39.90 |
| Average Volume (20 Days) | 254,793 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MBGYY had revenue of 163.66 billion and earned 8.00 billion in profits. Earnings per share was 8.26.
| Revenue | 163.66B |
| Gross Profit | 28.24B |
| Operating Income | 10.05B |
| Pretax Income | 11.48B |
| Net Income | 8.00B |
| EBITDA | 15.21B |
| EBIT | 10.05B |
| Earnings Per Share (EPS) | 8.26 |
Balance Sheet
The company has 24.91 billion in cash and 124.51 billion in debt, giving a net cash position of -98.87 billion.
| Cash & Cash Equivalents | 24.91B |
| Total Debt | 124.51B |
| Net Cash | -98.87B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 107.71B |
| Book Value Per Share | 110.75 |
| Working Capital | 28.47B |
Cash Flow
In the last 12 months, operating cash flow was 24.51 billion and capital expenditures -4.76 billion, giving a free cash flow of 19.75 billion.
| Operating Cash Flow | 24.51B |
| Capital Expenditures | -4.76B |
| Free Cash Flow | 19.75B |
| FCF Per Share | n/a |
Margins
Gross margin is 17.25%, with operating and profit margins of 6.14% and 4.89%.
| Gross Margin | 17.25% |
| Operating Margin | 6.14% |
| Pretax Margin | 7.02% |
| Profit Margin | 4.89% |
| EBITDA Margin | 9.29% |
| EBIT Margin | 6.14% |
| FCF Margin | 12.07% |
Dividends & Yields
This stock pays an annual dividend of 0.81, which amounts to a dividend yield of 5.71%.
| Dividend Per Share | 0.81 |
| Dividend Yield | 5.71% |
| Dividend Growth (YoY) | -19.41% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 9.79% |
| Buyback Yield | 6.98% |
| Shareholder Yield | 12.26% |
| Earnings Yield | 14.67% |
| FCF Yield | 36.22% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on February 1, 2018. It was a forward split with a ratio of 4.
| Last Split Date | Feb 1, 2018 |
| Split Type | Forward |
| Split Ratio | 4 |
Scores
MBGYY has an Altman Z-Score of 1.37 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.37 |
| Piotroski F-Score | 5 |